04:42 PM EDT, 03/20/2024 (MT Newswires) -- Myriad Genetics ( MYGN ) said late Wednesday the US Patent and Trademark Office granted it a patent covering the use of its blood-collection devices to determine fetal sex.

The patent protects the company's SneakPeek Snap products in the country through at least 2040, Myriad said, and it also covers technology to improve the accuracy of fetal sex tests.